SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-007795
Filing Date
2023-03-24
Accepted
2023-03-24 16:05:35
Documents
72
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20221231_10k.htm   iXBRL 10-K 1374281
2 EXHIBIT 3.1 ex_488532.htm EX-3.1 33099
3 EXHIBIT 3.2 ex_488533.htm EX-3.2 134757
4 EXHIBIT 10.14 ex_489418.htm EX-10.14 51485
5 EXHIBIT 10.15 ex_489419.htm EX-10.15 49201
6 EXHIBIT 21.1 ex_489420.htm EX-21.1 6623
7 EXHIBIT 23.1 ex_492494.htm EX-23.1 2862
8 EXHIBIT 31.1 ex_482211.htm EX-31.1 8910
9 EXHIBIT 31.2 ex_482212.htm EX-31.2 8944
10 EXHIBIT 32.1 ex_482213.htm EX-32.1 6286
16 d01.jpg GRAPHIC 3972
17 image01.jpg GRAPHIC 13049
18 image03.jpg GRAPHIC 15654
19 image04.jpg GRAPHIC 21805
  Complete submission text file 0001437749-23-007795.txt   5534570

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA dffn-20221231.xsd EX-101.SCH 44809
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20221231_def.xml EX-101.DEF 314554
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20221231_lab.xml EX-101.LAB 274650
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20221231_pre.xml EX-101.PRE 340073
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20221231_cal.xml EX-101.CAL 32209
66 EXTRACTED XBRL INSTANCE DOCUMENT dffn20221231_10k_htm.xml XML 560617
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 23759887
SIC: 2834 Pharmaceutical Preparations